0001144204-12-040458.txt : 20120723 0001144204-12-040458.hdr.sgml : 20120723 20120723060752 ACCESSION NUMBER: 0001144204-12-040458 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20120720 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120723 DATE AS OF CHANGE: 20120723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc. CENTRAL INDEX KEY: 0001083446 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 87042699 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-25809 FILM NUMBER: 12973482 BUSINESS ADDRESS: STREET 1: 450 NORTH BRAND BLVD., STREET 2: SUITE 600 CITY: GLENDALE STATE: CA ZIP: 91203 BUSINESS PHONE: 818-507-4617 MAIL ADDRESS: STREET 1: 450 NORTH BRAND BLVD., STREET 2: SUITE 600 CITY: GLENDALE STATE: CA ZIP: 91203 FORMER COMPANY: FORMER CONFORMED NAME: SICLONE INDUSTRIES INC DATE OF NAME CHANGE: 19990413 8-K 1 v319214_8-k.htm CURRENT REPORT

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 20, 2012

 

APOLLO MEDICAL HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   000-25809   20-8046599
(State or Other Jurisdiction   (Commission File   (I.R.S. Employer
of Incorporation)   Number)   Identification Number)

 

700 N. Brand Blvd., Suite 450, Glendale, CA 91203

(Address of principal executive offices) (zip code)

 

(818) 396-8050

(Registrant's telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 

Item 8.01 Other Events.

 

On July 9, 2012, Apollo Medical Holdings, Inc. issued a press release, attached hereto as Exhibit 99.1, announcing the Company had been selected to participate in the Medicare Shared Savings Program (“MSSP”) Accountable Care Organization (ACO), a multifaceted new program sponsored by the Centers for Medicare and Medicaid Services (CMS). On July 10, 2012, the Company issued a follow up press release, attached as Exhibit 99.2, relating to the Company’s selection to participate in the MSSP.

 

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits.

 

99.1 Press Release of Apollo Medical Holdings, Inc. dated July 9, 2012
99.2 Press Release of Apollo Medical Holdings, Inc. dated July 10, 2012

 

 

2

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  APOLLO MEDICAL HOLDINGS, INC.
   
Dated: July 20, 2012 By:  /s/ Warren Hosseinion
  Name: Warren Hosseinion
  Title:     Chief Executive Officer

 

 

3

 
 

 

 

 

 

 

 

 

 

 

EX-99.1 2 v319214_ex99-1.htm PRESS RELEASE - JULY 9 2012

 

EXHIBIT 99.1

 

 

 

 

July 9, 2012

 

FOR IMMEDIATE RELEASE

 

ApolloMed ACO To Participate As A Medicare Shared Savings Program Accountable Care Organization

 

Voluntary, New Care Coordination Program Created To Offer High Quality Service And Care To Beneficiaries Through Partnership with Medicare

 

Glendale, California -- ApolloMed ACO, today announced it has been selected to participate in the Medicare Shared Savings Program (Shared Savings Program) Accountable Care Organization (ACO), a multifaceted new program sponsored by the Centers for Medicare and Medicaid Services (CMS).

 

Through the Shared Savings Program, ApolloMed ACO will work with CMS to provide Medicare fee-for-service beneficiaries with high quality service and care, while reducing the growth in Medicare expenditures through enhanced care coordination.

 

 

 

Media Contact:

 

Nidia Flores

ApolloMed ACO

(818) 396-8050

nflores@apollomed.net

 

 

For more information about the Shared Savings Program, visit the CMS ACO website at:

 

www.medicare.gov/acos.html

 

 

 
 

GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!`@$`2`!(``#_X0G@17AI9@``34T`*@````@`!P$2``,` M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q M``(````;````<@$R``(````4````C8=I``0````!````I````-````!(```` M`0```$@````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`Q,CHP-SHR M,2`Q-SHQ-#HQ,````````Z`!``,````!``$``*`"``0````!```!5*`#``0` M```!````=0`````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0`` M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```BJ```` M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B M95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\, M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`-P"@`P$B``(1`0,1`?_=``0` M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$` M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$% M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B M$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=7 M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]522224I)4SU&MSRVKW`:;^Q_JJQ7:'C MS1,2-P@$%(DDD@E22222E))))*4DDDDI22222E))))*4DDDDI22222G_T/55 M3ZMQ]-@FM[2QX',.&L?RDZ'S#P*);%RNDU M/RGD`[:ZXWN'G]%K4?J=?5\.;\6\?9@=6"MNY@_E.<'.L8C]!QWXV+94]P>1 M:XBQOYS8;L?M^DS^4QWYZO7VT5LB]P#;"*P#^<7>W8!^=N4DIUDT`D.U7;&( MW#4F)\Z3C?:'!M-M]8;6X MN/IL]['V>UUGZ/U/YM6.I_77HO2\^[`R_6;=0P/);67-<7`/KJK+3[K;-WM7 M%_6(]:?5T2SJ56/BXQ+6X&)C[B:ZP:/Y^RS=N?Z?I?0QM;O\`&FP6`$!H M+6[7/8ZOV_O\`L_PB MS;/\8_U?98X,9DW4,=M.575-4GB"7-L]T>S]'^D_P:YXS7]9?K5]FC3`S3I^ M\6T/=_X.B=/93_XV74#`'Z9QD<[FVTBK_J:TE-S_`!A=0>^KHV1@9+VTY!>] MKZ7N8'M/V=S''TRW=[7?G*>1DY(_QG8]`OM%!:)I#W>F?U?(=_-;O3^E_)7. M]5)/U7^K4_O90'P%S`U;V1_^53'_`*@_]MLA)3L=1^OO1,#,MQ-F1DOQR1>Z MBL.8P@[7A[WOK^@[VO\`Y?L6@SZR=,MZ75U2ES[<:YVQNUOO#QNW5V5NVN8] MCF>Y<=]06LLZ=U]V0!N>P"XGF'-R'63_`&W/5?ZM%W_,^V?HC/$?'[/7N3\< M1*<8G8E;DD8P)'0/;#ZT=+-S:@;-I@>J6PP3^\2=WM_.=L4\3ZQ].R\H8U>\ M.>2*WN;#7$:Z:[O=^9O:L?KK6C`Z2``!Z<$>1;2K'5P!]9<``0(J_P"KL4_M M8R!0.HGU_P`VP^Y,$ZC0QZ?ONAF?6'`Q+W8Y%EUE?\YZ3=P;X[G$M^C^GGJ`>?0&A$'=NG;Z6S_2;ES_21U%^=U`XAHWESO6.0'$0;+?H;/\`IH&3 MC_9N@EC+ZLAIRP=U#MS1^B=[7&&^[VL2]B%B-ZW&]=^+?^ZKWIT95I4J^B;K MG6ZLZFDX;[:75N=ZC)+"00-KOT;MKF[OY2ZYRQN^K5PY;XCR5M)$&C:B+>7O&0U\ M"NQMG8!K@[_HJUTOI&0[(;FY@+37_,L>9=N/^$?.[;M_,8MY)2'.:H"KZL8Q M"[)M"W':'`^'`5/ZP=#Q^N].=@WO=5[FV5VL@EKV\.VN]KV[7.8]O[BTDE&3 M;(\=9_B[%U5`OZMDW78Q`I>\-LOJN`WJ7^,6W"- MMF.Y]375WTG:^M[*?4KL8_\`DKT5)!3S_0?J?A](=E777/S\C,::[K;@-6.. MZQFW7=ZS_=<][_TBS?\`QN*FL?B4]5RJNFV6"QV(-I$B-OO/Y[6M;ML?7^97 M]/8NR224\[UGZEX74L;I^)5<_#HZ8"VIC&M=(/I_3-G_`!7TD6SZK56?6>OZ MQ?:7BRL`?9]K=ABNS'^G]/\`PN];J22GD\SZ@5/R\J_I_4;^GU9V[[3CU@%C M@\E]C/S?T3W.?^C_`);_`/!_HUHU_57"HZ/5TG&L?7779ZKK3#GO>=V]]F@; M[MRVTD8R,2"-P@@$4=BY>=T)F91BTFYS!B-V@@`[M&-]T_\`%J>7T=F5U*C/ M-KF.HVQ6`"#MM%).]R>FNU_\[YD>W'MO7_-^5Q\KZNLLR;24ZXC=?M3&$8_** MM__2]527RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22G MZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI__9_^T.FE!H;W1O.$))30/S```````)```````` M```!`#A"24T$"@```````0``.$))32<0```````*``$``````````CA"24T# M]0``````2``O9F8``0!L9F8`!@```````0`O9F8``0"AF9H`!@```````0`R M`````0!:````!@```````0`U`````0`M````!@```````3A"24T#^``````` M<```_____________________________P/H`````/__________________ M__________\#Z`````#_____________________________`^@`````____ M_________________________P/H```X0DE-!`````````(``3A"24T$`@`` M````!``````X0DE-!`@``````!`````!```"0````D``````.$))300>```` M```$`````#A"24T$&@`````#20````8``````````````'4```%4````"@!5 M`&X`=`!I`'0`;`!E`&0`+0`Q`````0`````````````````````````!```` M``````````%4````=0`````````````````````!```````````````````` M`````!`````!````````;G5L;`````(````&8F]U;F1S3V)J8P````$````` M``!28W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<````````` M`$)T;VUL;VYG````=0````!29VAT;&]N9P```50````&7!E```` M`$YO;F4````)=&]P3W5T```&<@```(J@`8``'_V/_@ M`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2````` M`?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X. M#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M_\``$0@`-P"@`P$B``(1`0,1`?_=``0`"O_$`3\```$%`0$!`0$!```````` M``,``0($!08'"`D*"P$``04!`0$!`0$``````````0`"`P0%!@<("0H+$``! M!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S M-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4 MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($ M!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\` M]522224I)4SU&MSRVKW`:;^Q_JJQ7:'CS1,2-P@$%(DDD@E22222E))))*4D MDDDI22222E))))*4DDDDI22222G_T/553ZMQ]-@FM[2QX',.&L?RDZ'S#P*);%RNDU/RGD`[:ZXWN'G]%K4?J=?5\.;\6\ M?9@=6"MNY@_E.<'.L8C]!QWXV+94]P>1:XBQOYS8;L?M^DS^4QWYZO7VT5LB M]P#;"*P#^<7>W8!^=N4DIUDT`D.U7;&(W#4F)\Z3C?:'!M-M]8;6XN/IL]['V>UUGZ/U/YM6.I_77HO2\ M^[`R_6;=0P/);67-<7`/KJK+3[K;-WM7%_6(]:?5T2SJ56/BXQ+6X&)C[B:Z MP:/Y^RS=N?Z?I?0QM;O\`&FP6`$!H+6[7/8ZOV_O\`L_PBS;/\8_U?98X,9DW4,=M.575-4GB" M7-L]T>S]'^D_P:YXS7]9?K5]FC3`S3I^\6T/=_X.B=/93_XV74#`'Z9QD<[F MVTBK_J:TE-S_`!A=0>^KHV1@9+VTY!>]KZ7N8'M/V=S''TRW=[7?G*>1DY(_ MQG8]`OM%!:)I#W>F?U?(=_-;O3^E_)7.]5)/U7^K4_O90'P%S`U;V1_^53'_ M`*@_]MLA)3L=1^OO1,#,MQ-F1DOQR1>ZBL.8P@[7A[WOK^@[VO\`Y?L6@SZR M=,MZ75U2ES[<:YVQNUOO#QNW5V5NVN8]CF>Y<=]06LLZ=U]V0!N>P"XGF'-R M'63_`&W/5?ZM%W_,^V?HC/$?'[/7N3\<1*<8G8E;DD8P)'0/;#ZT=+-S:@;- MI@>J6PP3^\2=WM_.=L4\3ZQ].R\H8U>\.>2*WN;#7$:Z:[O=^9O:L?KK6C`Z M2``!Z<$>1;2K'5P!]9<``0(J_P"KL4_M8R!0.HGU_P`VP^Y,$ZC0QZ?ONAF? M6'`Q+W8Y%EUE?\YZ3=P;X[G$M^C^GGJ`>?0&A$'=NG;Z6S_2;ES_2 M1U%^=U`XAHWESO6.0'$0;+?H;/\`IH&3C_9N@EC+ZLAIRP=U#MS1^B=[7&&^ M[VL2]B%B-ZW&]=^+?^ZKWIT95I4J^B;KG6ZLZFDX;[:75N=ZC)+"00-KOT;M MKF[OY2ZYRQN^K5PY;XCR5M)$&C:B+>7O&0U\"NQMG8!K@[_HJUTOI&0[(;FY@+37 M_,L>9=N/^$?.[;M_,8MY)2'.:H"KZL8Q"[)M"W':'`^'`5/ZP=#Q^N].=@WO M=5[FV5VL@EKV\.VN]KV[7.8]O[BTDE&3;(\=9_B[%U5`OZMDW78Q`I>\-LOJN`WJ7^,6W"-MF.Y]375WTG:^M[*?4KL8_\`DKT5 M)!3S_0?J?A](=E777/S\C,::[K;@-6..ZQFW7=ZS_=<][_TBS?\`QN*FL?B4 M]5RJNFV6"QV(-I$B-OO/Y[6M;ML?7^97]/8NR224\[UGZEX74L;I^)5<_#HZ M8"VIC&M=(/I_3-G_`!7TD6SZK56?6>OZQ?:7BRL`?9]K=ABNS'^G]/\`PN]; MJ22GD\SZ@5/R\J_I_4;^GU9V[[3CU@%C@\E]C/S?T3W.?^C_`);_`/!_HUHU M_57"HZ/5TG&L?7779ZKK3#GO>=V]]F@;[MRVTD8R,2"-P@@$4=BY>=T)F91B MTFYS!B-V@@`[M&-]T_\`%J>7T=F5U*C/-KF.HVQ6`"#MM%).]R>F MNU_\[YD>W'MO7_-^5Q\KZNLLR;24ZXC=?M3&$8_**M__2]527RJDDI^JDE\JI)*?JI)?* MJ22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22G MZJ27RJDDI__9.$))300A``````!3`````0$````/`$$`9`!O`&(`90`@`%`` M:`!O`'0`;P!S`&@`;P!P````$@!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`G)E4WI.5&-Z:V,Y9"<_/@H\>#IX;7!M971A('AM M;&YS.G@])V%D;V)E.FYS.FUE=&$O)R!X.GAM<'1K/2=835`@=&]O;&MI="`S M+C`M,C@L(&9R86UE=V]R:R`Q+C8G/@H\&EF/2=H='1P.B\O;G,N M861O8F4N8V]M+V5X:68O,2XP+R<^"B`@/&5X:68Z0V]L;W)3<&%C93XQ/"]E M>&EF.D-O;&]R4W!A8V4^"B`@/&5X:68Z4&EX96Q81&EM96YS:6]N/C,T,#PO M97AI9CI0:7AE;%A$:6UE;G-I;VX^"B`@/&5X:68Z4&EX96Q91&EM96YS:6]N M/C$Q-SPO97AI9CI0:7AE;%E$:6UE;G-I;VX^"B`\+W)D9CI$97-C&UL;G,Z<&1F/2=H M='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O)SX*(#PO&%P.DUE=&%D871A M1&%T93XR,#$R+3`W+3(Q5#$W.C$T.C$P+3`U.C`P/"]X87`Z365T861A=&%$ M871E/@H@(#QX87`Z0W)E871O&%P34TZ1&]C=6UE;G1)1#X*(#PO#IX;7!M971A/@H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*/#]X<&%C:V5T M(&5N9#TG=R<_/O_B#%A)0T-?4%)/1DE,10`!`0``#$A,:6YO`A```&UN=')2 M1T(@6%E:(`?.``(`"0`&`#$``&%C'0`````0V]P>7)I9VAT("AC*2`Q.3DX($AE=VQE='0M4&%C:V%R M9"!#;VUP86YY``!D97-C`````````!)S4D="($E%0S8Q.38V+3(N,0`````` M````````$G-21T(@245#-C$Y-C8M,BXQ```````````````````````````` M``````````````````````````````````````!865H@````````\U$``0`` M``$6S%A96B``````````````````````6%E:(````````&^B```X]0```Y!8 M65H@````````8ID``+>%```8VEA96B`````````DH```#X0``+;/9&5S8P`` M```````6245#(&AT='`Z+R]W=W`&,`:`!M M`'(`=P!\`($`A@"+`)``E0":`)\`I`"I`*X`L@"W`+P`P0#&`,L`T`#5`-L` MX`#E`.L`\`#V`/L!`0$'`0T!$P$9`1\!)0$K`3(!.`$^`44!3`%2`5D!8`%G M`6X!=0%\`8,!BP&2`9H!H0&I`;$!N0'!`$!Z0'R`?H"`P(,`A0" M'0(F`B\".`)!`DL"5`)=`F<"<0)Z`H0"C@*8`J("K`*V`L$"RP+5`N`"ZP+U M`P`#"P,6`R$#+0,X`T,#3P-:`V8#<@-^`XH#E@.B`ZX#N@/'`],#X`/L`_D$ M!@03!"`$+00[!$@$501C!'$$?@2,!)H$J`2V!,0$TP3A!/`$_@4-!1P%*P4Z M!4D%6`5G!7<%A@66!:8%M07%!=4%Y07V!@8&%@8G!C<&2`99!FH&>P:,!IT& MKP;`!M$&XP;U!P<'&09!ZP'OP?2!^4'^`@+"!\(,@A& M"%H(;@B"")8(J@B^"-((YPC["1`))0DZ"4\)9`EY"8\)I`FZ"<\)Y0G["A$* M)PH]"E0*:@J!"I@*K@K%"MP*\PL+"R(+.0M1"VD+@`N8"[`+R`OA"_D,$@PJ M#$,,7`QU#(X,IPS`#-D,\PT-#28-0`U:#70-C@VI#<,-W@WX#A,.+@Y)#F0. M?PZ;#K8.T@[N#PD/)0]!#UX/>@^6#[,/SP_L$`D0)A!#$&$0?A";$+D0UQ#U M$1,1,1%/$6T1C!&J$)%ZX7TA?W&!L80!AE&(H8KQC5&/H9(!E%&6L9D1FW&=T: M!!HJ&E$:=QJ>&L4:[!L4&SL;8QN*&[(;VAP"'"H<4AQ['*,0!YJ'I0>OA[I'Q,?/A]I'Y0?OQ_J(!4@02!L()@@Q"#P(1PA M2"%U(:$ASB'[(B--@U$S5--8Y",$)R0K5"]T,Z M0WU#P$0#1$=$BD3.11)%546:1=Y&(D9G1JM&\$25^!8+UA]6,M9&EEI6;A:!UI66J9:]5M%6Y5;Y5PU7(9O5\/7V%?LV`%8%=@JF#\84]AHF'U8DEBG&+P8T-CEV/K9$!D ME&3I93UEDF7G9CUFDF;H9SUGDV?I:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_ M;%=LKVT(;6!MN6X2;FMNQ&\>;WAOT7`K<(9PX'$Z<95Q\')+%V/G:;=OAW5G>S>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA M?(%\X7U!?:%^`7YB?L)_(W^$?^6`1X"H@0J!:X'-@C""DH+T@U>#NH0=A("$ MXX5'A:N&#H9RAM>'.X>?B`2(:8C.B3.)F8G^BF2*RHLPBY:+_(QCC,J-,8V8 MC?^.9H[.CS:/GI`&D&Z0UI$_D:B2$9)ZDN.339.VE""4BI3TE5^5R98TEI^7 M"I=UE^"83)BXF229D)G\FFB:U9M"FZ^<')R)G/>=9)W2GD">KI\=GXN?^J!I MH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E.*6IIAJFBZ;]IVZGX*A2J,2I-ZFIJARJ MCZL"JW6KZ:QK_UP'#`[,%GP>/"7\+;PUC#U,11Q,[%2\7(QD;&P\=!Q[_(/%$ MXIZ#+HO.E&Z=#J6^KEZW#K^^R&[1'M MG.XH[K3O0._,\%CPY?%R\?_RC/,9\Z?T-/3"]5#UWO9M]OOWBO@9^*CY./G' M^E?ZY_MW_`?\F/TI_;K^2_[<_VW____N``Y!9&]B90!D``````'_VP"$``8$ M!`0%!`8%!08)!@4&"0L(!@8("PP*"@L*"@P0#`P,#`P,$`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P!!P<'#0P-&!`0&!0.#@X4%`X.#@X4$0P,#`P, M$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`'4! M5`,!$0`"$0$#$0'_W0`$`"O_Q`&B````!P$!`0$!```````````$!0,"!@$` M!P@)"@L!``("`P$!`0$!``````````$``@,$!08'"`D*"Q```@$#`P($`@8' M`P0"!@)S`0(#$00`!2$2,4%1!A-A(G&!%#*1H0<5L4(CP5+1X3,68O`D'EZ>WQ]?G]SA(6&AXB)BH MN,C8Z/@I.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ$0`"`@$"`P4%!`4& M!`@#`VT!``(1`P0A$C%!!5$382(&<8&1,J&Q\!3!T>$C0A528G+Q,R0T0X(6 MDE,EHF.RP@=STC7B1(,75),("0H8&28V11HG9'15-_*CL\,H*=/C\X24I+3$ MU.3T976%E:6UQ=7E]4969G:&EJ:VQM;F]D=79W>'EZ>WQ]?G]SA(6&AXB)BH MN,C8Z/@Y25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOK_V@`,`P$``A$#$0`_ M`/5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O_T/5.*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O_T?5.*NQ5V*NQ5V*N M)`%2:#%6@Z'H0<:5O%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J__TO5.*NQ5V*NQ M5+]4U>&Q4+LT[?93^)RW'C,OB/'@.J:V. MO:/=D)!>1R.>B\@&/T'*9X9QYAMCEB>13'*FQV*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5Y)^9/YS:KY3\R'2K:PBN(Q&)/472?\`.26NKN*O?H)#)#'(10NH8C MYBN*K\5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL58?YQ\[7>@ZC#:PVZ2K+%ZA9 MB:@\B.V9VETHR1))3O,,^NZ;)=S1+$R2M&%6M*``UW^>5:G", M[%7__U/5.*NQ5V*I-YPF:+R[>.O4*!][`9?IA>0-.?IFU(<`%E/EC2VU"4R25%M']H_P`Q\,Q,^3A'FY.*/$S"ZTO3[NU^JW$" MR6_^^ST_#,&.20-@[N5*`(HL`\R^019*UWIP,EL-Y(CNR>X_R*L4\Y?F;Y5\IE8M2G+WC[I:0CG)3 MQ8#[(Q5A"_\`.2GETR<6TRX"5^UR4[?*F*L_\G?F!Y:\VP/)I,Y,L0!FMI!Q MD6O?B>WOBJ&\Z_F9Y>\H3V\.JB8O<@M'Z2.*I._YZ>1UT(ZMZDM&D:&* MU*4E=EZGC_+_`)6*I;HW_.1'E*]O4MKRWGL$D(5)FHZU/\U`.(Q5ZI#-%-$D ML3AXI`&1U-00=P0<58=YR_-GRGY5F-K=S-<7]*FU@'(K_KG]G%6)6_\`SDGY M9>4+/I]Q%%WD!#D?[$#%7I?EOS/HOF/3EU#2;@3P'9AT9#_*Z_LG%7SK_P`Y M`?\`*?-_S#IA5Z7^1/\`Y+6?_C)-_P`1&!7SC/\`\="3_F)/_)W"K[:@DCBL M(I)&"1I$K.[&@`"[DG`KSC7_`/G('R;IMT]M:++J+QDJ[Q#C'4?RL?M8JIZ- M_P`Y#^3[VY2"\AFL/4/%97'-`3_,13B,5>G)=V\EH+N)Q)`4]19$-0RTK480 M+02QA/S,\O/.L($H9F"5*;5)IF8=!.K<4:R%TMU3\R]$LYS#"CW3*:.R;+7V M)ZX<>AG(6=D3UD0:&Z.T/SOHNK))Q*4S099,@@++$Y/S7T MH2$1VLKIV:H'X4S-'9TN]Q#KH]R?Z!YNT?6RR6LA6=15H7%&IXCQS%S::6/G MRVME:R75U((X(A5W.51B9&@V2D(BRQ"3\U='68JEO*\5?[S8; M?ZN9P[/G7-Q#KHWR8M^8.JV6J:C97=G)SB:VW[$'F=B,R]'C,(D'O<75S$B" M.YE?Y4_\H_/_`,Q+_J&8?:/UCW.5H?H/O9IF`YKL5?_5]4XJ[%7$T%<52C7( M!?:9=VG4R1DJ/$KN/U9?B/#(%JR"XD/)(97!X$$.#0KWKX9NB'5@O8]!LDL] M*MX5&_`,Y\2V^:/-/BD2[;'&HA'Y4S<5#`@BH.Q&*O.?,.B+9:DZQBD,OQQC MPKVS:8&7<37PLX\FWLDEBUK(:M;FB$]>)_IFOU4:-][EX) M;4R$],Q6]\I>:?*/GW6_.%_>3Z3=NEQ=,B3\*@0AJ*1OT"XJ]!\[_DYY.TCR M%+>PO1MZ4IOBJ4?F=Y+A M\I>9Y-+MW:6R>-98'?=J-7X2>Y&*O9ORJ\W3)^4D][RI_=C%7 M@FDV=]YH\TP6\TA>[U2X_?2=_B-6(^C%7K7YL?E!Y;T+R,<@?F>F*J7_.0'_*?-_S# MIA5Z7^1/_DM9_P#C)-_Q$8%?.,__`!T)/^8D_P#)W"KZ-_/7S%MDTT,MC?Q%TB8\N+(:,*^&^*O3?R%U^?4/(U_I\[EVTQFCC9MSP="P'R M7)1YAC+D6+,A>X*+]IGXK\R6VO5FRS MSEY(T_1=*BO+221G#*DH!32.6% MBX\2M*9+M`>B_-CHCZZ0GYA:I)>>8IXBQ,5G^Z1.P(ZGZP"1>1_*5OKLL\EV[K;04%$-"6/OF3J]2<=5S:--@&3GR2[S5H(T3 M5VLTO$^.6:?-XD;:\^+@E3//RJ_XX$__`#$O^H9KNT/K'N<[0_1\ M6:9@.:[%7__6]4XJ[%5*X?C'DHA!2J:X*.&4[J:C+@&LEA'F;0O1O5UBS7G9 MR2!KJ)=S&U=S3^5LS\&6QPGFX.;%1XAR>FVS*UM$R_9**1\B,U,N;LAR5,"7 M8JD'FF!)5@8;LI8;9DZ\$\^_G_JJ:E/IWEF-(H;=S&U[(O-G8;'@O;?H<58IJN@_ MFOY@T:XUS6Y9QI<2>L%N7XH5\8T&*I?^4!K^8>D'Q8_JQ5F__.2__'3TC_C& M^*IU_P`XU+%^A-48?WIG`;QI0TQ5CG_.207_`!)II'VC`:GZ<54O)3W`_([S MAU"*!Z1'N1RQ5A_Y5?\`DP]"_P",_P#QJ<5?1_YMJC?EYK(<`KZ0V/3[0Q5\ M\_DU_P"3(T;YR?\`$<*IM_SD!_RGS?\`,.F*O2_R)_\`):S_`/&2;_B(P*^< M9_\`CH2?\Q)_Y.X5>T?\Y(,XM/+"@G@5E)':H1*8%7?\XR_WVN_\\?U'%5__ M`#DR%_W"F@Y?O`#WI48JM_YQR,GZ,\QB@]/X:GORX')1YAC+D4+#_O>G_&8? M\2SHS]+H1S>R>9_^44N?^,(_4,T6G_O1[WA_FA_RC8_XS)^O-9H/[QV&M^AB7Y9?\I2/^,$G\,S=?\`W?Q<31?W MGP27S,2?,.I%_M>NW*N7X/H'N:7_/4UC!+:W,BVSH&A424`0C;; M,>>;""01NWPQ92!1V4U_+[S29UEDC5F+AG8MN=ZDX?SN.D?EM&\?VW_X,Y?V=]!][1KOK'N9!^5/_*/S_P#,2_ZAF-VC]8]SD:'Z#[V:9@.: M[%7_U_5.*NQ50O5)@8CJN^2AS06/7$O7?,H!I)2Y[N2)BR&G8@[@CP(RT1MK M)3&V\Y1Q*$N8:!0`&C]O;*I:6^19C-7-5D\]Z.@)XR$CL`/ZY$:2:3J(I!K' MYB74B-%I\7HAMA*^[;^V9.+1`?4T9-4>BU],O*1UV&5996S@$3JJR-I=XL7]XT$@3_6*&F4M MCXOL95L]?MYKT56VO$>Z%.R2`OM]&*OH/\S_`,S_`"<_DJXL["\2ZNK^)5@M MXZU"M3=NPXC%7CWY0"GYA:0/!C^K%6<_\Y+?\=32/^,;XJD_Y'?F#HWE>\O[ M36IOJ]G>!7CN""51DK4-2I^*N*I+^;_G"P\T>;&O-.UU%%XSMT$B=`3[C%6OSX\X:5Y@\P6<.F3BXMM/B97F3[ M#/(033_5IBK._P#G'_1)[/R5J>HRB@U)V:&HH>,:%?Q.2CS#&7(L>A_XZ"?\ M91_Q+.C/TNA'-[+YG_Y12Y_XPC]0S1:?^]'O=SF_NR\I\I?\I%I__&5\QM<]&B\LQ"XG6*XM(_ M3:(UY$J*+3YYK\^EF52/N MS/E@QQA9'(.%'-.4N;(?S7LGXV%YN52L+-\]]\Q>SI_?TH9J.LM*@,.QIENMT\IT8\VO29Q"P4L\Z:Y;ZQK37%O4P1J(XV/<#>N M7:7$80H\VK491.5AFWY5?\<"?_F)?]0S7]H_6/N*L:UJQEMF,BBL#=QV]CF7BG?O:)QICUQ+[YE`-)*6SR=1A[?RYC:G4"(X1]3;@P\1L\F? M-!R8DC-=Q.?32V@)I2F/$O"C$144*O0962R;Q5Y+YM_YQ]TC6-7FU+3[U[`W M+%YX.(9.1W++WW.*M>7O^<=_+]@+A]1NGOII8GBAV"I&7%.8'=ABK7E[_G'Z MUT36K+5;;6IVELY%D"E%HP'53_K8JQO_`)R6_P".GI'_`!C?%4L_*_\`+/2/ M.GE:\^LR/;7UM<$074=":$;JP/48JRK2_P#G&O3(KR.74=3DN+="&:!%"\Z= MF/ABKV2SM+:SM8K6VC$5O`H2*-=@JJ*`#%7G'G;\BO+WF+4)-3M9WTV\EWF$ M8!C=OYB.Q^6*L9A_YQE@]5?6UE_2K\?!!RI[5Q5ZKY0\F:)Y4TT6.E1<58\I MIFW>1O%CBK$_/?Y+67FW73JTVI2VKF,1^DBJ1MWWQ5D7DCR1!Y5\NOHL5R]R MCL[>LX`/QBG08J\]?_G&G36G:7]-3U:0R4X)W;E3%7K]SIMI=ZRGK]^*KM&_P"<;-&M M[M9=3U&2[@0@_5T`0-3LQZXJ]=@TZUMM/%A:QB"V2/THT04"K2F$&B@BPPQ? MRJM5G67Z_)4/SIQ'8US8?R@:JG!_(B^;+]2TQ;[2Y+!G*+(@0N.HIF%CR<,N M)S)PXHTQ?2ORSMM/U"WO%O9',#!@A44-,R\FO,HD5S<6&C$2#:?^9=`CUS3O MJ3RF$'*W(S8N,4E7EOR%!HFIB^2[>9@C1\&``^+OME^?6' M)'AIIPZ40E=IIYA\L:;KL`2Y!25/[N=/M+E.'42QG9MS8(S&[$C^4J\C2_-. MU5WIF;_*/DXGY#S9#Y;\CZ9HDIN`QN+LB@E<#X1_D@9BY]7+)MR#D8=-&&_5 M.=4TRTU.RDL[M.<4@H?$'L1E&/(8&PW3@)"BP=_REB]0^G?L(J[54A3[ROYTCF: M;5+""E3^06=M[OX/EOEPUGDU'3>:/ MT[R/H]HXDE!N9!N#)T!^0RN>KF>6S..GB&0*JJH50`HV`&PS%;VZ8J[%78J[ M%78J[%78J\M_.#\L]=\X7MA-ILD4:6RLLGJ&G7PQ5,_R@\B:OY0TJ[M-2>.2 M2>7U$,9J*8JS_%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J__2]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J__3]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ__4]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J__5]4XJ M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J D[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J__9 ` end EX-99.2 4 v319214_ex99-2.htm PRESS RELEASE - JULY 10 2012

 

EXHIBIT 99.2

 

 

 

July 10, 2012

 

 

 

ApolloMed ACO Selected To Participate In A Transformative New Initiative Sponsored by the Centers for Medicare and Medicaid Services

 

Glendale, California – Apollo Medical Holdings, Inc. (“ApolloMed”) (OTCQB – AMEH), a leading provider of hospitalist, critical care and multi-disciplinary care management services to the healthcare community, announces that ApolloMed ACO, one of its subsidiaries, has been officially selected by the Centers for Medicare and Medicaid Services (“CMS”) to participate in the Medicare Shared Savings Program. (“MSSP”)

The Medicare Shared Savings Program model is designed to encourage the development of Accountable Care Organizations (“ACOs”), which can be comprised of hospitals, doctors and other health care providers who work together and are accountable for quality outcomes and the overall patient experience, while reducing the growth in Medicare expenditures.

Through the MSSP model, ApolloMed ACO will work with CMS on a program for Medicare beneficiaries that enhances the engagement between patients and their medical providers through the coordination of care and services across all aspects of their health needs. Patients will benefit from improved quality and outcomes as a result of a more efficient and coordinated approach among providers.

“We are pleased that our ACO has been selected by CMS to participate in the Medicare Shared Savings Program. Our involvement at this early stage of accountable care positions our company extremely well to thrive during this critical phase of health care,” stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc. and ApolloMed ACO, Inc. “We feel a deep sense of responsibility for our patients and will focus on delivering coordinated, patient-centered, high quality and cost-effective care for them.”

“The accountable care model represents the future of health care delivery in the United States,” stated Eli Hendel, M.D., Chairman of the Board of ApolloMed ACO, Inc. “We are very excited about the opportunity to provide leadership in achieving the goals of the Medicare Shared Savings Program.”

Over one hundred primary care physicians from Greater Los Angeles and Central California joined ApolloMed ACO.

 
 

 

About Apollo Medical Holdings, Inc.

ApolloMed is a leading provider of integrated medical care and management services plus multi-disciplinary care management services targeting inefficiencies in healthcare payer and provider networks. The Company’s integrated model combines its Accountable Care Organization, hospitalist medicine, critical care medicine, 24-hour physician call center, case management, high-risk medicine program and transition care management.

 

For more information, please visit our website: www.apollomed.net

 

Media Contact:

 

Nidia Flores

Apollo Medical Holdings, Inc.

818-396-8050

nflores@apollomed.net